621 related articles for article (PubMed ID: 29207027)
1. Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).
Dong R; Zhang M; Hu Q; Zheng S; Soh A; Zheng Y; Yuan H
Int J Mol Med; 2018 Feb; 41(2):599-614. PubMed ID: 29207027
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
Lima T; Perpétuo L; Henrique R; Fardilha M; Leite-Moreira A; Bastos J; Vitorino R
Mol Biol Rep; 2023 Mar; 50(3):2763-2778. PubMed ID: 36583779
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases.
Hara A; Niwa M; Noguchi K; Kanayama T; Niwa A; Matsuo M; Hatano Y; Tomita H
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32138174
[TBL] [Abstract][Full Text] [Related]
4. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner.
Kim SJ; Chun KH
BMB Rep; 2020 Apr; 53(4):173-180. PubMed ID: 32172730
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic role of galectin-3].
Gudowska M; Chrostek L
Pol Merkur Lekarski; 2014 Dec; 37(222):348-52. PubMed ID: 25715576
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3: A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology.
Hara A; Niwa M; Kanayama T; Noguchi K; Niwa A; Matsuo M; Kuroda T; Hatano Y; Okada H; Tomita H
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899694
[TBL] [Abstract][Full Text] [Related]
7. The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target.
Zhou Z; Feng Z; Sun X; Wang Y; Dou G
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958500
[TBL] [Abstract][Full Text] [Related]
8. Effect of haemodialysis and residual renal function on serum levels of galectin-3, B-type natriuretic peptides and cardiac troponin T.
Roberts MA; Srivastava PM; Hare DL; Ierino FL
Nephrology (Carlton); 2018 Dec; 23(12):1131-1138. PubMed ID: 29028161
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells.
Tian L; Chen K; Cao J; Han Z; Gao L; Wang Y; Fan Y; Wang C
Mol Med Rep; 2015 Oct; 12(4):4995-5002. PubMed ID: 26165519
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 in angiogenesis and metastasis.
Funasaka T; Raz A; Nangia-Makker P
Glycobiology; 2014 Oct; 24(10):886-91. PubMed ID: 25138305
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.
Sciacchitano S; Lavra L; Morgante A; Ulivieri A; Magi F; De Francesco GP; Bellotti C; Salehi LB; Ricci A
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29373564
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of galectin-3 in chronic kidney disease patients: a systematic review and meta-analysis.
Zhang T; Cao S; Yang H; Li J
Int Urol Nephrol; 2019 Jun; 51(6):1005-1011. PubMed ID: 30963453
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 as a novel biotarget in cardiovascular alterations associated to development of severe aortic stenosis.
Arrieta V; Sádaba JR; Álvarez V; Rodríguez JA; López-Andrés N
An Sist Sanit Navar; 2019 Aug; 42(2):199-208. PubMed ID: 31317953
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer.
Kataoka Y; Ohshio Y; Teramoto K; Igarashi T; Asai T; Hanaoka J
Oncol Rep; 2019 Feb; 41(2):853-862. PubMed ID: 30535445
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3: an open-ended story.
Dumic J; Dabelic S; Flögel M
Biochim Biophys Acta; 2006 Apr; 1760(4):616-35. PubMed ID: 16478649
[TBL] [Abstract][Full Text] [Related]
16. The Role of Galectin-3 in the Kidneys.
Chen SC; Kuo PL
Int J Mol Sci; 2016 Apr; 17(4):565. PubMed ID: 27089335
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 in cancer.
Song L; Tang JW; Owusu L; Sun MZ; Wu J; Zhang J
Clin Chim Acta; 2014 Apr; 431():185-91. PubMed ID: 24530298
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.
Hrynchyshyn N; Jourdain P; Desnos M; Diebold B; Funck F
Arch Cardiovasc Dis; 2013 Oct; 106(10):541-6. PubMed ID: 24090952
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 as a multifunctional protein.
Krześlak A; Lipińska A
Cell Mol Biol Lett; 2004; 9(2):305-28. PubMed ID: 15213811
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target.
Boutin L; Dépret F; Gayat E; Legrand M; Chadjichristos CE
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
